Connor, Clark & Lunn Investment Management (CC&L)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,498
Closed -$2.72M 1618
2023
Q3
$2.72M Buy
23,498
+820
+4% +$94.9K 0.01% 534
2023
Q2
$2.33M Sell
22,678
-57
-0.3% -$5.86K 0.01% 572
2023
Q1
$2.48M Sell
22,735
-196
-0.9% -$21.4K 0.01% 508
2022
Q4
$2.61M Buy
+22,931
New +$2.61M 0.02% 479
2022
Q2
Sell
-113,872
Closed -$12M 1261
2022
Q1
$12M Buy
113,872
+93,159
+450% +$9.8M 0.06% 204
2021
Q4
$2.23M Buy
20,713
+13,880
+203% +$1.5M 0.01% 500
2021
Q3
$748K Buy
+6,833
New +$748K ﹤0.01% 696
2021
Q2
Sell
-22,409
Closed -$2.06M 1169
2021
Q1
$2.06M Buy
+22,409
New +$2.06M 0.01% 554
2019
Q3
Sell
-13,775
Closed -$331K 1162
2019
Q2
$331K Buy
+13,775
New +$331K ﹤0.01% 806
2018
Q3
Sell
-61,775
Closed -$1.02M 1169
2018
Q2
$1.02M Buy
61,775
+17,850
+41% +$296K 0.01% 608
2018
Q1
$624K Sell
43,925
-221,279
-83% -$3.14M ﹤0.01% 540
2017
Q4
$3.87M Buy
265,204
+71,099
+37% +$1.04M 0.02% 323
2017
Q3
$2.46M Sell
194,105
-105,445
-35% -$1.34M 0.01% 385
2017
Q2
$3.56M Buy
+299,550
New +$3.56M 0.02% 312
2016
Q2
Sell
-57,225
Closed -$948K 967
2016
Q1
$948K Buy
57,225
+47,300
+477% +$784K 0.01% 467
2015
Q4
$215K Buy
+9,925
New +$215K ﹤0.01% 690
2015
Q3
Sell
-176,800
Closed -$6.14M 818
2015
Q2
$6.14M Buy
+176,800
New +$6.14M 0.06% 138
2015
Q1
Sell
-377,100
Closed -$4.86M 637
2014
Q4
$4.86M Buy
377,100
+247,700
+191% +$3.19M 0.04% 158
2014
Q3
$1.59M Buy
+129,400
New +$1.59M 0.01% 237